Global Acute Repetitive Seizures Market to Reach $22 Billion by 2030
The global market for Acute Repetitive Seizures estimated at US$1.7 Billion in the year 2023, is expected to reach US$22 Billion by 2030, growing at a CAGR of 44.7% over the analysis period 2023-2030. Diastat Rectal Gel, one of the segments analyzed in the report, is expected to record a 46.2% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the USL-261 segment is estimated at 42.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $420.2 Million, While China is Forecast to Grow at 52.1% CAGR
The Acute Repetitive Seizures market in the U.S. is estimated at US$420.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 52.1% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 36.4% and 40.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 38.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.7 Billion by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook